Depletion of pulmonary intravascular macrophages prevents hyperacute pulmonary xenograft dysfunction

Transplantation

Volumn 81, Issue 8, 2006, Pages 1157-1164

  Cantu, Edward ^a   Gaca, Jeffrey G ^a   Palestrant, Daniel ^a   Baig, Kamran ^a   Lukes, Daniel J ^a,b   Gibson, Sarah E ^a   Gonzalez Stawinski, Gonzalo V ^a   Olausson, Michael ^b   Parker, William ^a   Davis, R Duane ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Clodronate; Lung; Macrophages; Swine; Xenotransplant

Indexed keywords

ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY BLOOD FLOW; ARTICLE; BABOON; CONTROLLED STUDY; GRAFT DYSFUNCTION; GRAFT FAILURE; GRAFT SURVIVAL; HEART TRANSPLANTATION; HYPERACUTE GRAFT REJECTION; KIDNEY TRANSPLANTATION; LUNG BLOOD FLOW; MACROPHAGE; NONHUMAN; PERFUSION; PRIORITY JOURNAL; SWINE; TRANSGENIC ANIMAL; XENOTRANSPLANTATION;

ANIMALS; BLOOD PRESSURE; COMPLEMENT C5A; ENDOTHELIUM, VASCULAR; GRAFT SURVIVAL; HEART RATE; LUNG; LUNG TRANSPLANTATION; MACROPHAGES; PAPIO; PULMONARY CIRCULATION; SWINE; TRANSPLANTATION, HETEROLOGOUS; VASCULAR RESISTANCE;

EID: 33646792940     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000169758.57679.2a     Document Type: Article

References (57)

1. Good AH, Cooper DK, Malcolm AJ, et al. Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant Proc 1992; 24: 559.
2. Daniels LJ, Platt JL. Hyperacute xenograft rejection as an immunologic barrier to xenotransplantation. Kidney Int 1997; 58: S28.
3. Lin SS, Weidner BC, Byrne GW, et al. The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J Clin Invest 1998; 101: 1745.
4. Dalmasso AP, Vercellotti GM, Fischel RJ, et al. Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am J Pathol 1992; 140: 1157.
5. Pruitt SK, Bollinger RR, Collins BH, et al. Effect of continuous complement inhibition using soluble complement receptor type 1 on survival of pig-to-primate cardiac xenografts. Transplantation 1997; 63: 900.
6. Leventhal JR, Dalmasso AP, Cromwell JW, et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 1993; 55: 857.
7. Yeatman M, Daggett CW, Parker W, et al. Complement-mediated pulmonary xenograft injury: studies in swine-to-primate orthotopic single lung transplant models. Transplantation 1998; 65: 1084.
8. Lau CL, Daggett WC, Yeatman MF, et al. The role of antibodies in dysfunction of pig-to-baboon pulmonary transplants. J Thor Cardiovas Surg 2000; 120: 29.
9. Collins BJ, Blum MG, Parker RE, et al Thromboxane mediates pulmonary hypertension and lung inflammation during hyperacute lung rejection. J Appl Physiol 2001; 90: 2257.
10. Winkler GC, Cheville NF. Postnatal colonization of porcine lung capillaries by intravascular macrophages: an ultrastructural, morphometric analysis. Microvascular Res 1987; 33: 224.
11. Staub NC. Pulmonary intravascular macrophages. Ann Rev Physiol 1994; 56: 47.
12. Brain JD, Molina RM, DeCamp MM, Warner AE. Pulmonary intravascular macrophages: their contribution to the mononuclear phagocyte system in 13 species. Am J Physiol 1999; 276: L146.
13. Miyamoto K, Schultz E, Heath T, et al. Pulmonary intravascular macrophages and hemodynamic effects of liposomes in sheep. J Appl Physiol 1988; 64: 1143.
14. Chitko-McKown CG, Chapes SK, Brown RE, et al. Porcine alveolar and pulmonary intravascular macrophages: comparison of immune functions. J Leukocyte Biol 1991; 50: 364.
15. Tector AJ, Fridell JA, Watanabe T, et al. Pulmonary injury in recipients of discordant hepatic and renal xenografts in the dog-to-pig model. Xenotransplantation 1998; 5: 44.
16. Bertram TA, Overby LH, Danilowicz R, et al. Pulmonary intravascular macrophages produce prostaglandins and leukotrienes in vitro. Chest 1988; 93: 82S.
17. van Rooijen N. The liposome-mediated macrophage 'suicide' technique. J Immunol Meth 1989; 124: 1.
18. van Rooijen N. Liposome-mediated elimination of macrophages. Res Immunol 1992; 143: 215.
19. Sone Y, Nicolaysen A, Staub NC. Effect of particles on sheep lung hemodynamics parallels depletion and recovery of intravascular macrophages. J Appl Physiol 1997; 83: 1499.
20. Sone Y, Serikov KB, Staub NC. Intravascular macrophage depletion attenuates endotoxin in lung injury in anesthetized sheep. J Appl Physiol 1999; 87: 1354.
21. Diamond LE, Quinn CM, Martin MJ, et al. A human CD46 transgenic pig model system for the study of discordant xenotransplantation. Transplantation 2001; 71: 132.
22. Gaca JG, Palestrant D, Lukes DJ, et al. Prevention of acute lung injury in swine: depletion of pulmonary intravascular macrophages using liposomal clodronate. J Surg Res 2003; 112: 19.
23. Daggett CW, Yeatman M, Lodge AJ, et al. Total respiratory support from swine lungs in primate recipients. J Thor Cardiovas Surg 1998; 115: 19.
24. Diamond LE, Byrne GW, Schwarz A, et al. Analysis of the control of the anti-gal immune response in a non-human primate by galactose alpha1-3 galactose trisaccharide-polyethylene glycol conjugate. Transplantation 2002; 73: 1780.
25. Gonzalez-Stawinski GV, Daggett CW, Lau CL, et al. Non-anti-Gal alpha 1-3 Gal antibody mechanisms are sufficient to cause hyperacute lung dysfunction in pulmonary xenotransplantation. J Am Coll Surg 2002; 194: 765.
26. Gaca JG, Lesher A, Aksoy O, et al. Disseminated intravascular coagulation in association with pig-to-primate pulmonary xenotransplantation. Transplantation 2002; 73: 1717.
27. Bryant LR, Eiseman B, Avery M. Studies of the porcine lung as an oxygenator for human blood. J Thor Cardiovas Surg 1968; 55: 255.
28. Riquet MWT, LePimpec-Barthes F, Eme D, et al. Sheep lung as xenograft oxygenator of human blood: an ex vivo study. Xenotransplantation 1995; 2: 32.
29. Waldhausen JA, WR, Spencer FC, Bahnson HT. Study of the canine lung as an oxygenator of human and canine blood in extracorporeal circulation. Surgery 1957; 42: 726.
30. Campbell GS, CN, Brown EB. Total cardiac by-pass in humans utilizing a pump and heterologous lung oxygenator (dog lungs). Surgery 1956; 40: 364.
31. Stevens RB, Platt JL. The pathogenesis of hyperacute xenograft rejection. Am J Kidney Dis 1992; 20: 414.
32. Pierson RN 3rd, Tew DN, Konig WK, et al. Pig lungs are susceptible to hyperacute rejection by human blood in a working ex vivo heart-lung model. Transplant Proc 1994; 26: 1318.
33. Pierson RN 3rd, Dunning JJ, Konig WK, et al. Mechanisms governing the pace and character of pig heart-lung rejection by human blood. Transplant Proc 1994; 26: 2337.
34. Pierson RN 3rd, Kasper-Konig W, Tew DN, et al. Hyperacute lung rejection in a pig-to-human transplant model: the role of anti-pig antibody and complement. Transplantation 1997; 63: 594.
35. Macchiarini P, Mazmanian GM, Oriol R, et al. Ex vivo lung model of pig-to-human hyperacute xenograft rejection. J Thor Cardiovas Surg 1997; 114: 315.
36. Daggett CW, Yeatman M, Lodge AJ, et al. Swine lungs expressing human complement-regulatory proteins are protected against acute pulmonary dysfunction in a human plasma perfusion model. J Thor Cardiovas Surg 1997; 113: 390.
37. Pierson RN 3rd, Pino-Chavez G, Young VK, et al. Expression of human decay accelerating factor may protect pig lung from hyperacute rejection by human blood. J Heart Lung Transplant 1997; 16: 231.
38. Macchiarini P, Oriol R, Azimzadeh A, et al. Evidence of human non-alpha-galactosyl antibodies involved in the hyperacute rejection of pig lungs and their removal by pig organ perfusion. J Thorac Cardiovasc Surg 1998; 116: 831.
39. Yeatman M, Daggett CW, Lau CL, et al. Human complement regulatory proteins protect swine lungs from xenogeneic injury. Ann Thorac Surg 1999; 67: 769.
40. Winkler GC. Pulmonary intravascular macrophages in domestic animal species: review of structural and functional properties. Am J Anal 1988; 181: 217.
41. Macchiarini P, Oriol R, Azimzadeh A, et al. Evidence of human non-alpha-galactosyl antibodies involved in the hyperacute rejection of pig lungs and their removal by pig organ perfusion. J Thorac Cardiovasc Surg 1998; 116: 831.
42. Zhang JP, Blum MG, Chang AC, et al. Immunohistologic evaluation of mechanisms mediating hyperacute lung rejection, and the effect of treatment with K76-COOH, FUT-175, and anti-Gal column immunoadsorption. Xenotransplantation 1999; 6: 249.
43. Pfeiffer S, Zorn GL 3rd, Kelishadi S, et al. Role of anti-Gal alpha13Gal and anti-platelet antibodies in hyperacute rejection of pig lung by human blood. Ann Thorac Surg 2001; 72: 1681.
44. Azimzadeh A, Zorn GL 3rd, Blair KS, et al. Hyperacute lung rejection in the pig-to-human model. 2. Synergy between soluble and membrane complement inhibition. Xenotransplantation 2003; 10: 120.
45. Schroder C, Pfeiffer S, Wu G, et al. Effect of complement fragment 1 esterase inhibition on survival of human decay-accelerating factor pig lungs perfused with human blood. J Heart Lung Transplant 2003; 22: 1365.
46. Miyata Y, Platt JL. Xeno-still stuck without alphaGal. Nat Biotechnol 2003; 21: 359.
47. Fine R, Shaw JO, Rogers WR. Effects of C5a on baboon alveolar macrophage migration. Am Rev Respir Dis 1981; 123: 110.
48. McCarthy K, Henson PM. Induction of lysosomal enzyme secretion by alveolar macrophages in response to the purified complement fragments C5a and C5a des-arg. J Immunol 1979; 123: 2511.
49. Riedemann NC, Guo RF, Sarma VJ, et al. Expression and function of the C5a receptor in rat alveolar epithelial cells. J Immunol 2002; 168: 1919.
50. Foreman KE, Vaporciyan AA, Bonish BK, et al. C5a-induced expression of P-selectin in endothelial cells. J Clin Invest 1994; 94: 1147.
51. Ikeda K, Nagasawa K, Horiuchi T, Tsuru T, Nishizaka H, Niho Y. C5a induces tissue factor activity on endothelial cells. Thromb Haemostasis 1997; 77: 394.
52. Ward PA. Role of complement, chemokines, and regulatory cytokines in acute lung injury. Ann N Y Acad Sci 1996; 796: 104.
53. Engler RL, Roth DM, del Balzo U, Ito BR. Intracoronary C5a induces myocardial ischemia by mechanisms independent of the neutrophil: leukocyte filters desensitize the myocardium to C5a. FASEB J 1991; 5: 2983.
54. Crowell RE, Heaphy E, Valdez YE, et al. Alveolar and interstitial macrophage populations in the murine lung. Exp Lung Res 1992; 18: 435.
55. de Perrot M, Liu M, Waddell TK, Keshavjee S. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 2003; 167: 490.
56. Fiser SM, Tribble CG, Long SM, et al. Lung transplant reperfusion injury involves pulmonary macrophages and circulating leukocytes in a biphasic response. J Thorac Cardiovasc Surg 2001; 121: 1069.
57. Eppinger MJ, Deeb GM, Bolling SF, Ward PA. Mediators of ischemia-reperfusion injury of rat lung. Am J Pathol 1997; 150: 1773.